J Clin Med:额叶纤维性脱发:额叶发际线与正常头皮的组织病理学比较

2022-08-20 医路坦克 MedSci原创

额部纤维性脱发(FFA)是一种淋巴细胞增生性脱发,已成为最常见的瘢痕性脱发类型。本研究的目的是对FFA中临床受累区域和“正常外观”区域的组织病理学特征进行广泛的比较。

额部纤维性脱发(FFA)是一种淋巴细胞增生性脱发,已成为最常见的瘢痕性脱发类型。在临床上,它的特征是额叶或顶叶,甚至枕叶发际线的进行性后退,导致脱发的瘢痕带。

毛囊免疫豁免权的丧失被认为是瘢痕性脱发发生的起点。在毛囊暴露于免疫攻击后,由未知触发因素引发的针对漏斗和峡部的细胞毒性T细胞自身免疫反应,可能导致隆起区干细胞的破坏,进而导致毛囊的不可逆转的破坏。FFA的典型组织病理学特征包括上毛囊周围的苔藓样淋巴细胞浸润,即峡部和漏斗,以及同心性小叶周围板层纤维化。深部卵泡受累较少见,但可能在FFA样本中发现,滤泡间表皮通常不受影响。

本研究的目的是对FFA中临床受累区域和“正常外观”区域的组织病理学特征进行广泛的比较。到目前为止,这是同类研究中规模最大的。此外,还评估了这两个区域的组织病理学改变与某些特定的临床或毛镜征象之间的关系。

对52例额叶纤维性脱发患者进行了横断面研究。对两个区域进行了活组织检查:额部发际线和看起来正常的头皮区域。额部发际线样本中皮脂腺减少/缺失的比例为80.8%,而“健康头皮”样本中皮脂腺的比例为42.3%(p=0.001)。92.3%的患者额部发际区和86.5%的“健康头皮”区有炎性细胞浸润(p=0.508),但前者的严重程度较高(p=0.013)。在额叶发际线活检中,70.6%的毛囊上皮有变化,而在“健康头皮”活检中,这一比例为48.1%(p=0.012)。在额部发际线和“健康头皮”活检组织中,纤维组织的改变分别占80.8%和53.8%(p=0.003)。

来自50号患者的图像。(a、c、e)显示临床受累最多的区域(额部发际线)的活检。淋巴样渗出明显,滤泡气孔基底层侵蚀明显。地衣红染色(E)显示漏斗周围有疤痕。(A)苏木精-伊红×20;(C)苏木-伊红×40;(E)柴田地衣×40)。(b,d,f)显示从外观正常的头皮区域进行的活组织检查。淋巴浸润物没有(A)和(C)明显,(F)的疤痕面积也比(E)的小。(B)苏木精-伊红×20;(D)苏木-伊红×40;(F)柴田地衣×40)。

来自47号患者的图像。(a、c、e)显示临床受累最多的区域(额部发际线)的活检。虽然淋巴样浸润性病变不像病例50那样明显,但漏斗周区有广泛的疤痕形成。(A)苏木精-伊红×20;(C)苏木-伊红×40;(E)柴田地衣×40)。(b,d,f)显示从外观正常的头皮区域进行的活组织检查。疤痕区域不那么突出,太阳弹力纤维增生症也是如此。(B)苏木精-伊红×20;(D)苏木-伊红×40;(F)柴田地衣×40)。

总之,额叶纤维性脱发的组织病理学特征在受影响的区域和临床未受影响的区域都是相同的。

文献来源: Porriño-Bustamante ML,  Pinedo-Moraleda FJ,  Fernández-Flores Á, Frontal Fibrosing Alopecia: A Histopathological Comparison of the Frontal Hairline with Normal-Appearing Scalp.J Clin Med 2022 Jul 15;11(14)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952429, encodeId=e738195242995, content=<a href='/topic/show?id=511c3e99330' target=_blank style='color:#2F92EE;'>#发际线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37993, encryptionId=511c3e99330, topicName=发际线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Apr 11 08:36:07 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928831, encodeId=177e192883197, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Tue Aug 23 19:36:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473530, encodeId=78ba14e353092, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611701, encodeId=e0251611e0116, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=)]
    2023-04-11 雕雕
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952429, encodeId=e738195242995, content=<a href='/topic/show?id=511c3e99330' target=_blank style='color:#2F92EE;'>#发际线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37993, encryptionId=511c3e99330, topicName=发际线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Apr 11 08:36:07 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928831, encodeId=177e192883197, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Tue Aug 23 19:36:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473530, encodeId=78ba14e353092, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611701, encodeId=e0251611e0116, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1952429, encodeId=e738195242995, content=<a href='/topic/show?id=511c3e99330' target=_blank style='color:#2F92EE;'>#发际线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37993, encryptionId=511c3e99330, topicName=发际线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Apr 11 08:36:07 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928831, encodeId=177e192883197, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Tue Aug 23 19:36:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473530, encodeId=78ba14e353092, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611701, encodeId=e0251611e0116, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=)]
    2022-08-18 jktdtl
  4. [GetPortalCommentsPageByObjectIdResponse(id=1952429, encodeId=e738195242995, content=<a href='/topic/show?id=511c3e99330' target=_blank style='color:#2F92EE;'>#发际线#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37993, encryptionId=511c3e99330, topicName=发际线)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=daa8281, createdName=雕雕, createdTime=Tue Apr 11 08:36:07 CST 2023, time=2023-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928831, encodeId=177e192883197, content=<a href='/topic/show?id=71f1e771115' target=_blank style='color:#2F92EE;'>#组织病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77711, encryptionId=71f1e771115, topicName=组织病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Tue Aug 23 19:36:07 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473530, encodeId=78ba14e353092, content=<a href='/topic/show?id=4fd1e102257' target=_blank style='color:#2F92EE;'>#病理学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71022, encryptionId=4fd1e102257, topicName=病理学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8ce7226273, createdName=jktdtl, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611701, encodeId=e0251611e0116, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Aug 18 14:36:07 CST 2022, time=2022-08-18, status=1, ipAttribution=)]

相关资讯

NEJM:抗药性局灶性癫痫的组织病理学研究

对于接受手术治疗的抗药性局灶性癫痫患者,海马硬化是成人最常见的组织病理学诊断,而中枢性皮质发育不良是儿童最常见的诊断。肿瘤是成年及未成年患者中次常见病变

Am J Rhinol Allergy:慢性鼻窦炎中空气污染物暴露与鼻窦组织病理检查结果的关系

空气污染会引起呼吸道上皮的炎症变化,并与哮喘和慢性阻塞性肺病等炎症的加重有关。然而,空气污染对慢性鼻窦炎发病机制的影响研究有限,目前还没有文献报道污染物暴露如何影响慢性鼻窦炎患者的鼻窦组织病理学。

JCEM:原发性醛固酮增多症的遗传和组织病理学间的异质性

这一病例凸显了在单个原发性醛固酮增多症(PA)患者在组织学、类固醇生成和体细胞突变方面出现的多发性肾上腺皮质腺瘤的复杂的肿瘤异质性。这些发现表明,原发性醛固酮增多症(PA)的并发症状可能涉及多样化的、多功能性的肾上腺腺瘤。

Ann Neurol:卒中患者颅内血栓的组织病理学特征

由此可见,该研究的这些发现可能有助于确定癌症相关卒中的治疗策略。

JAMA Dermatol:银屑病组织病理学诊断的视觉线索

炎症性皮肤病的临床和组织病理学诊断可能具有挑战性。我们将这两个组织学标准的总和称为ñsign。本文描述了ñsign在临床实践中作为银屑病诊断的视觉线索的潜在用途。

Neurology病例:Ollier病中经组织病理学证实的颅内内生软骨瘤/低级别软骨肉瘤和IDH1突变的弥漫性胶质瘤

Ollier病中经组织病理学证实的颅内内生软骨瘤/低级别软骨肉瘤和IDH1突变的弥漫性胶质瘤病例分享。